Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-11-20
pubmed:abstractText
Although liposome-encapsulated clodronate has been used as a means to deplete macrophages from certain tissues, target leukocyte subtypes within the kidney are not clearly known under normal and pathologic conditions. The present study was therefore conducted to examine the effects of liposome clodronate on renal infiltrating cell type following unilateral ureteral obstruction (UUO) and tried to correlate these changes to the mechanisms of early development of renal fibrosis. Renal infiltrating leukocyte subtypes and counts were determined by using multicolor flow cytometric analysis of cell suspensions from obstructed kidneys. UUO for 5 days elicited renal tubular apoptosis and renal fibrosis and showed 4-fold increase in renal leukocytes including monocytes/macrophages, dendritic cells, and T-cells. Repeated administration of liposome clodronate selectively depleted F4/80+ monocytes/macrophages and F4/80+ dendritic cells but not F4/80(-) dendritic cells or other cell types in both obstructed and non-obstructed kidneys. Tubular apoptosis and renal fibrosis were also significantly attenuated by liposome clodronate. Increased gene expression of TNF-alpha and TGF-beta observed in obstructed kidneys were markedly attenuated by depletion of renal mononuclear phagocytes. These findings suggest that F4/80+ monocytes/macrophages and/or F4/80+ dendritic cells play a pivotal role in the development of obstruction-induced tubular apoptosis and renal fibrosis, possibly through TNF-alpha and TGF-beta dependent mechanisms.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1347-8648
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
285-92
pubmed:meshHeading
pubmed-meshheading:19893275-Animals, pubmed-meshheading:19893275-Bone Density Conservation Agents, pubmed-meshheading:19893275-Bone Marrow Cells, pubmed-meshheading:19893275-Clodronic Acid, pubmed-meshheading:19893275-Cytokines, pubmed-meshheading:19893275-Dendritic Cells, pubmed-meshheading:19893275-Drug Carriers, pubmed-meshheading:19893275-Fibrosis, pubmed-meshheading:19893275-Flow Cytometry, pubmed-meshheading:19893275-Immunohistochemistry, pubmed-meshheading:19893275-In Situ Nick-End Labeling, pubmed-meshheading:19893275-Kidney, pubmed-meshheading:19893275-Kidney Diseases, pubmed-meshheading:19893275-Kidney Tubules, pubmed-meshheading:19893275-Leukocytes, pubmed-meshheading:19893275-Liposomes, pubmed-meshheading:19893275-Macrophages, pubmed-meshheading:19893275-Male, pubmed-meshheading:19893275-Mice, pubmed-meshheading:19893275-Mice, Inbred C57BL, pubmed-meshheading:19893275-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19893275-Ureteral Obstruction
pubmed:year
2009
pubmed:articleTitle
Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy.
pubmed:affiliation
Department of Urology, Osaka City University Medical School, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't